RETRACTED ARTICLE: Embelin alleviates weaned piglets intestinal inflammation and barrier dysfunction via PCAF/NF-κB signaling pathway in intestinal epithelial cells
Open Access
- 14 December 2022
- journal article
- retracted article
- Published by Springer Nature in Journal of Animal Science and Biotechnology
- Vol. 13 (1) , 1-10
Abstract
Background: Intestinal barrier plays key roles in maintaining intestinal homeostasis. Inflammation damage can severely destroy the intestinal integrity of mammals. This study was conducted to investigate the protective effects of embelin and its molecular mechanisms on intestinal inflammation in a porcine model. One hundred sixty 21-day-old castrated weaned pigs (Duroc × Landrace × Yorkshire, average initial body weight was 7.05 ± 0.28 kg, equal numbers of castrated males and females) were allotted to four groups and fed with a basal diet or a basal diet containing 200, 400, or 600 mg embelin/kg for 28 d. The growth performance, intestinal inflammatory cytokines, morphology of jejunum and ileum, tight junctions in the intestinal mucosa of piglets were tested. IPEC-1 cells with overexpression of P300/CBP associating factor (PCAF) were treated with embelin, the activity of PCAF and acetylation of nuclear factor-κB (NF-κB) were analyzed to determine the effect of embelin on PCAF/NF-κB pathway in vitro. Results: The results showed that embelin decreased (P < 0.05) serum D-lactate and diamine oxidase (DAO) levels, and enhanced the expression of ZO-1, occludin and claudin-1 protein in jejunum and ileum. Moreover, the expression levels of critical inflammation molecules (interleukin-1β, interleukin-6, tumor necrosis factor-α, and NF-κB) were down-regulated (P < 0.05) by embelin in jejunal and ileal mucosa. Meanwhile, the activity of PCAF were down-regulated (P < 0.05) by embelin. Importantly, transfection of PCAF siRNAs to IPEC-1 cell decreased NF-κB activities; embelin treatment downregulated (P < 0.05) the acetylation and activities of NF-κB by 31.7%–74.6% in IPEC-1 cells with overexpression of PCAF. Conclusions: These results suggested that embelin ameliorates intestinal inflammation in weaned pigs, which might be mediated by suppressing the PCAF/NF-κB signaling pathway.Keywords
Funding Information
- National Natural Science Foundation of China (32072742)
- National key research and development program (2021YFD1300300)
- Fellowship of China Postdoctoral Science Foundation (2022M711274)
This publication has 50 references indexed in Scilit:
- Selective inhibition of PCAF suppresses microglial-mediated β-amyloid neurotoxicityInternational Journal of Molecular Medicine, 2013
- Dietary Selenium Deficiency Partially Rescues Type 2 Diabetes–Like Phenotypes of Glutathione Peroxidase-1–Overexpressing Male Mice3The Journal of Nutrition, 2012
- Tight junctions on the move: molecular mechanisms for epithelial barrier regulationAnnals of the New York Academy of Sciences, 2012
- Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancerJournal of Molecular Signaling, 2010
- Regulation of Cellular Metabolism by Protein Lysine AcetylationScience, 2010
- Intestinal mucosal barrier function in health and diseaseNature Reviews Immunology, 2009
- Regulation of ornithine aminotransferase gene expression and activity by all-transretinoic acid in Caco-2 intestinal epithelial cellsThe Journal of Nutritional Biochemistry, 2008
- Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis modelTranslational Research, 2007
- Postnatal Epithelial Growth of the Small Intestine in the Rat Occurs by Both Crypt Fission and Crypt HyperplasiaDigestive Diseases and Sciences, 2006
- Role of NF-κB in immune and inflammatory responses in the gutGut, 1998